The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64
Screening commercially insured individuals for colorectal cancer is a high-value service, costing less per year of life saved than breast or cervical cancer screening.
Service Setting Impact on Costs for Bevacizumab-Treated Oncology Patients
For patients with lung or colorectal cancer, bevacizumab treatment patterns and healthcare costs varied by the setting of treatment initiation (physician office vs hospital outpatient).
